Visit Mabqi at Booth #40 during the 13th Antibody Industrial Symposium (AIS)

Mabqi is excited to attend the 13th Antibody Industrial Symposium (AIS 2025), in Tours, France, from June 25th to 26th.

Our team will be actively involved during the congress:

• Johanna Marines, PharmD, Head of Preclinical team, will be giving a talk on 25th at 4PM during the session “Innovative Approaches and New trend Technologies”.  She will share the latest in vitro and in vivo results of our lead asset MQI-201, a first-in-class anti-TRPV6 antibody in oncology
• Sylvain Yon, CEO, will  take part in a panel discussion on funding for biotech companies
• We are also exhibiting ! Come and meet us booth #40 to discuss our latest developments in therapeutic antibody discovery and development.

Jointly organized by LabEx MAbImprove and MabDesign, AIS is a premier international event bringing together scientists, clinicians, and industry leaders to explore the latest advances and challenges in therapeutic antibodies, recombinant proteins, and related biomedicines, from early R&D to clinical stages.

We look forward to seeing you in Tours!